RxDoctor Payments Data

Max Lewis, MD

Family Medicine · Zionsville, INNPI 1750606125

Payments from drug & device makers

$15,367in general payments, 2019–2025

Across 984 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Pfizer$872
  • Amgen$832
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$15,03998%
  • Education$3282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)179$2,472
Novo Nordisk119$1,478
Lilly USA, LLC99$1,232
AstraZeneca(2 entities)61$1,120
Pfizer72$872
Amgen49$832
Novartis32$617
Bayer23$542
Johnson & Johnson31$538
Astellas Pharma US Inc22$483
GSK26$391
Otsuka America Pharmaceutical, Inc.17$384
Harmony Biosciences LLC8$358
Jazz Pharmaceuticals Inc.16$312
Boehringer Ingelheim17$281
Takeda Pharmaceuticals U.S.A., Inc.17$274
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$226
Antares Pharma, Inc.10$153
Mylan Specialty L.p.8$149
Sanofi-aventis U.S. LLC9$149
Ironshore Pharmaceuticals Inc.9$148
Dexcom, Inc.6$141
Merck8$116
Corcept Therapeutics5$116
Eisai Inc.5$100
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$93
Supernus Pharmaceuticals, Inc.5$93
Exact Sciences5$87
Teva Pharmaceuticals USA, Inc.5$85
Radius Health, Inc.5$83
Paratek Pharmaceuticals, Inc.5$80
Abbott4$75
Viatris Specialty LLC3$68
Amarin Pharma, Inc.4$66
Idorsia Pharmaceuticals US Inc3$55
Assertio Therapeutics, Inc.4$54
Nestle Healthcare Nutrition Inc.4$53
Medtronic(2 entities)3$48
Daiichi Sankyo Inc.3$48
Endo Pharmaceuticals Inc.3$48
Genentech USA, Inc.4$47
Mannkind Corporation2$45
Biohaven Pharmaceutical Holding Company Ltd.3$43
Mayne Pharma Commercial LLC1$43
Kowa Pharmaceuticals America, Inc.2$38
Azurity Pharmaceuticals, Inc.2$35
Promius Pharma LLC2$35
Biogen2$34
Corium, LLC3$32
Amneal Pharmaceuticals LLC2$31
Lundbeck LLC2$30
Cranial Technologies, Inc2$29
Arbor Pharmaceuticals, Inc.2$28
Ironwood Pharmaceuticals, Inc2$27
Axsome Therapeutics, Inc.1$25
E.r. Squibb & Sons, L.L.C.2$22
Almatica Pharma LLC1$22
Upsher-smith Laboratories LLC1$21
Inspire Medical Systems, Inc.1$19
Actelion Pharmaceuticals US, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,367 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$44,856
Medicare patients
142
Services billed
4,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide62$59,215
VraylarCariprazine Hcl22$47,973
TrulicityDulaglutide32$46,019
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$36,526
OzempicSemaglutide25$34,680
EliquisApixaban31$33,206
XareltoRivaroxaban22$30,968
FarxigaDapagliflozin Propanediol35$29,504
JardianceEmpagliflozin28$27,674
MyrbetriqMirabegron17$13,356
LyricaPregabalin12$10,236
Aimovig AutoinjectorErenumab-Aooe14$10,175
Memantine Hcl ErMemantine Hcl15$5,552
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen104$4,528
Xigduo XrDapaglifloz Propaned/Metformin11$3,639

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,232$105,23494 claims
AbbVieVraylar, Synthroid$2,472$49,62639 claims
PfizerEliquis, Lyrica$872$43,44343 claims
GSKTrelegy Ellipta$391$36,52647 claims
Novo NordiskOzempic$1,478$34,68025 claims
Johnson & JohnsonXarelto$538$30,96822 claims
AstraZenecaFarxiga$1,120$29,50435 claims
Boehringer IngelheimJardiance$281$27,67428 claims
Astellas Pharma US IncMyrbetriq$483$13,35617 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$31$2,149243 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Zionsville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →